| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications.
nuMedica is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shasta Regional Medical Center is a 226-bed acute care, medical and surgical facility with a full range of ancillary services. We have been serving far Northern California since 1945. Our hospital has a highly efficient and expanded Emergency Department with minimal patient wait times, a technologically advanced cardiac cath lab available 24/7, an accredited Stroke Team and digital (filmless) radiology services. We have more than 600 registered nurses, technicians, and support personnel working alongside more than 300 physicians on staff. Together, our staff is committed to combining the latest proven technology with personal care and attention to help our patients get better.
Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.